Join
Live feed
·
INSIDERFilingvia Quantisnow
Sarepta Therapeutics Inc. logo

Director Behrens M Kathleen exercised 10,500 shares at a strike of $13.71 and covered exercise/tax liability with 6,494 shares, increasing direct ownership by 2% to 197,482 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SRPT (Sarepta Therapeutics Inc.) and more on Quantisnow.